How'd you fix Amcor's revenue issues in 2026?

The two paths Amcor could take in 2026

Amcor entered FY26 with a real strategic fork, and the two directions behave very differently.

Path A — Full portfolio integration. Keep flexibles and rigid together, merge every sales org, plant, and P&L under one operating model, and grind out the full $260M synergy promise across FY26–FY27. The upside is scale: one commercial face to CPG and pharma buyers, a bundle story that pairs extrusion film with thermoform trays, and procurement leverage across roughly 27 combined converting lines. The downside is speed. Full integration is a 24-36 month program, and Amcor's problem is a quarterly earnings problem, not a three-year one. Every month of matrix confusion is a month Sealed Air, Sonoco, and Crown Holdings get to re-paper the accounts Amcor just inherited.

Path B — Surgical fix, then integrate. Freeze the org chart where it is, appoint one commercial owner per top account immediately, and spend the first two quarters on revenue and margin moves that do not require a completed integration: price architecture, spec wins, secondary-packaging attach, and a decision on North America beverage rigid. Integration of back-office systems, ERP, and procurement continues in parallel but stops being the headline.

Path B is the better fit for the actual constraint. Amcor does not have an integration problem as much as it has a commercial discipline problem wearing an integration costume. The Berry close created overlapping reps, duplicated vendor contracts, and no single P&L owner per customer — and those are fixable in weeks, not years. The RevOps and commercial-operations layer is where the fastest dollars sit.

The trade-off is real: Path B leaves some duplicate cost in the system longer. Amcor keeps paying for redundant sales overlays and overlapping plant overhead while it chases revenue. That is an acceptable trade if the incremental gross margin from share gains and pricing exceeds the carrying cost of the duplicates — which, at typical flexible-packaging gross margins, it usually does. The discipline is to set a hard date (end of FY26) by which the duplicates are gone regardless.

How to decide between the two paths

The decision hinges on three questions: how fast does the synergy gap need to close, how defensible is the rigid portfolio, and how much customer disruption can the sales org absorb at once.

The logic in practice: if the synergy run-rate is tracking well behind plan, you cannot wait for a full integration to fix revenue — you fix revenue first and integrate second. If rigid is genuinely a low-margin, volume-declining grind, divesting or joint-venturing it frees both cash and management attention. And if the sales org is already absorbing merger disruption, adding a full systems integration on top of it in the same quarter is how you lose the top 20% of account managers to competitors.

A practical rule: score each path on time-to-first-dollar, execution risk, and reversibility. Path B wins time-to-first-dollar and reversibility; Path A wins on long-run cost structure. When the earnings calendar is the binding constraint, time-to-first-dollar wins.

The concrete numbers behind each path

Numbers make the fork decidable.

The synergy gap. Berry closed April 30, 2025. By Q1 FY26, only about $38M in synergies had been realized — roughly a $152M annualized run-rate against a $260M FY26 target. That is a run-rate gap north of $100M. Path A assumes that gap closes on schedule through integration; Path B assumes only $60M of incremental synergy capture in FY26 from sales-org consolidation and procurement, with the rest slipping to FY27.

The rigid drag. North America beverage rigid volumes have been running down roughly 5-12% year over year, and that business sits at the low end of the margin stack — think 3-5% operating margin, not the double-digit margins flexibles earns. If Amcor divests or joint-ventures it, a plausible cash range is in the low hundreds of millions, redeployable into flexibles footprint consolidation. Consolidating overlapping converting lines — merging roughly 27 lines into a smaller number of higher-utilization hubs — is where a 10-12% COGS reduction on the consolidated footprint becomes credible.

The pricing lever. Sustainability is currently buried in engineering specs. Recasting it as three commercial tiers — standard, recycled-content, and regenerative/takeback — supports a 3-7% price uplift on the SKUs that migrate. If 15-20% of food and healthcare SKUs move to a premium tier by end of 2026, that is a nine-figure revenue contribution with almost no volume requirement, because it is a mix and price move, not a demand-generation move.

The share-capture number. Winning 12-15 food-service and CPG specs currently held by competitors, at $15-40M annual contract value each, is a $200-500M revenue band depending on close rate. Even a 40% close rate moves the needle materially. Pair that with secondary-packaging attach — flexibles often sell the primary pack while the secondary pack is white space — and a $150-200M attach target over twelve months is not unrealistic.

The FX and passthrough reality. Currency and raw-material passthrough have been eating into reported revenue. Passing through only about 1% of raw-material inflation while customers push for 60-day terms means pricing discipline, not cost inflation, is the swing factor. That is another argument for Path B: price architecture is a commercial fix, not an integration deliverable.

Put together, Path B's FY26 exit looks like revenue stabilizing in the mid-to-high $15B range with adjusted EBITDA improving by roughly $90-135M versus the do-nothing base — driven mostly by $60M synergy capture, $120M of rigid COGS reduction, and the first tranche of premium-tier pricing.

Implementation details and sequencing

The sequencing matters as much as the moves. Here is how the first two quarters run.

Weeks 1-6 — Commercial reset. Appoint one P&L owner per top account. Today, a customer can be talking to a legacy Amcor rep and a legacy Berry rep simultaneously, which shatters price discipline. Collapse that to a single owner per account, and give those owners a deal desk with authority to commit volume and term. Target: 10-15 multi-year contracts above $10M ACV locked by end of Q1, each with committed volume rather than forecast volume.

Weeks 2-8 — Rigid decision. Make the North America beverage call. Indecision is itself a revenue bleed because customers and reps both stall. Either divest/JV and redeploy the cash, or commit to a footprint fix with a named owner and a date. In parallel, run the line-consolidation analysis on the combined converting footprint.

Weeks 4-12 — Demand sensing and competitive intel. Amcor has been forecasting on annual contracts while its customers destock on weekly cycles. Stand up a weekly demand pulse across food, healthcare, and beverage, and pair it with win/loss intelligence so the sales org knows within days why a spec went to a competitor and can counter inside a week rather than a quarter.

Weeks 6-20 — Premium tier rollout. Build the three tiers, train the field on the value conversation — compliant packaging avoids regulatory and retailer shelf-ban risk — and migrate the first wave of SKUs. This is where the fastest margin dollars land because it requires no new capacity.

End FY26 — Hard stop on duplicates. Whatever the integration status, the redundant sales overlays and duplicated vendor contracts come out on a fixed date. That is the discipline that keeps Path B from becoming permanent bloat.

FY27 — Bolt-on. Only after the commercial reset proves out does Amcor go shopping again: a smaller flexibles player in Asia or a premium healthcare thermoform converter. The point is to extend the lead in the wedges where scale creates customer lock, not to add more integration surface area.

The through-line: every move is owned by a named commercial leader with a date, a number, and a customer name attached. RevOps, not a transformation office, is the natural home for the tracking.

Related questions

Why did Amcor's Berry synergies fall so far behind?

Because the two sales orgs kept operating in parallel. With overlapping reps, duplicated vendor contracts, and no shared P&L per customer, procurement and pricing leverage never got consolidated, so realized synergies ran roughly $100M behind the annual target.

Is divesting North America beverage rigid the right call?

It is defensible. That business runs at low single-digit margins with volumes declining 5-12% year over year as customers shift to aluminum and glass. Divesting or joint-venturing frees cash and management attention for higher-margin flexibles.

Can sustainability actually raise Amcor's revenue?

Yes, if it is priced rather than donated. Packaging that meets recycled-content and takeback requirements helps customers avoid regulatory and retailer risk, which supports a 3-7% premium on migrating SKUs without needing volume growth.

What is the single fastest revenue lever?

Sales-org consolidation and the deal desk. Collapsing duplicate reps into one owner per account restores price discipline and lets Amcor commit volume on multi-year terms within weeks, unlike plant consolidation, which takes quarters.

FAQ

What were Amcor's main revenue issues in 2026? Three things compounded: a synergy shortfall from the Berry merger running roughly $100M behind the annual target, a structurally declining North America beverage rigid business, and heavy customer concentration in food and healthcare that made revenue vulnerable to destocking and spec changes. Currency drag and weak raw-material passthrough added pressure on reported revenue.

How big was the Berry synergy gap? Berry closed April 30, 2025, and by Q1 FY26 only about $38M of synergies had been realized — roughly a $152M annualized run-rate against a $260M FY26 target. That left a run-rate gap north of $100M, which is why a commercial fix had to run ahead of full integration.

Why is the rigid segment such a problem? North America beverage rigid sits at low single-digit operating margins while volumes decline 5-12% year over year as sustainability mandates push customers toward aluminum and glass. Low margin plus declining volume means it consumes management attention and capital without earning its keep.

What role does demand sensing play? Amcor historically forecast on annual contracts while customers destocked on weekly cycles. A weekly demand pulse across food, healthcare, and beverage gives the commercial team two-week visibility into spec changes and sourcing shifts instead of discovering them a quarter late.

How does competitive intelligence change the sales motion? Win/loss intelligence embedded in each deal lets Amcor learn within days why a spec went elsewhere and counter inside a week. Without it, the sales org finds out a quarter later, when the contract is already re-papered and the pricing conversation is over.

What is the realistic FY26 outcome? Revenue stabilizing in the mid-to-high $15B range with adjusted EBITDA improving roughly $90-135M over the do-nothing base, driven by $60M of synergy capture, about $120M of rigid COGS reduction, and the first wave of premium sustainability pricing. The full $260M synergy target realistically lands in FY27.

Sources

• https://www.amcor.com/investor-centre
• https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001748790
• https://www.packagingworld.com
• https://www.packagingdigest.com
• https://www.mckinsey.com/industries/paper-forest-products-and-packaging/our-insights
• https://www.weforum.org
• https://www.bloomberg.com
• https://www.reuters.com/markets/deals/

Related on PULSE

• How'd you fix Sealed Air's revenue issues in 2026?
• How'd you fix Sonoco's revenue issues in 2026?
• How'd you fix Crown Holdings' revenue issues in 2026?
• How do you run a post-merger sales org consolidation in 90 days?
• How do you price sustainability as a premium packaging tier?
• What does a RevOps deal desk actually own?